» Articles » PMID: 24661975

Use of Mesenchymal Stem Cells for Cutaneous Repair and Skin Substitute Elaboration

Overview
Publisher Elsevier
Specialty Biology
Date 2014 Mar 26
PMID 24661975
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Human mesenchymal stem cells (MSCs) are a heterogeneous population of fibroblast-like cells, which are present in different locations, including bone marrow, adipose tissue, extra-foetal tissues, gingiva and dermis. MSCs, which present multipotency capacities, important expansive potential and immunotolerance properties, remain an attractive tool for tissue repair and regenerative medicine. Currently, several studies and clinical trials highlight the use of MSCs in cutaneous repair underlining that their effects are essentially due to the numerous factors that they release. MSCs are also used in skin substitute development. In this study, we will first discuss the different sources of MSCs actually available. We will then present results showing that bone marrow-derived MSCs prepared according to Good Manufacturing Practices and included in a dermal equivalent are able to promote appropriate epidermis growth and differentiation. These data demonstrate that bone marrow-derived MSCs represent a satisfactory alternative to dermal fibroblasts in order to develop skin substitute. In addition, MSCs could provide a useful alternative to sustain epidermis development and to promote wound healing.

Citing Articles

Umbilical cord mesenchymal stem cells combined with autologous platelet-rich plasma for lower extremity venous ulcers: A case report and literature review.

Jiao L, Nie J, Duan L, Qiao X, Sui Y Medicine (Baltimore). 2024; 103(45):e40433.

PMID: 39533589 PMC: 11557112. DOI: 10.1097/MD.0000000000040433.


Combined treatment of umbilical cord Wharton's jelly-derived mesenchymal stem cells and platelet-rich plasma for a surgical patient with hospital-acquired pressure ulcer: a case report and literature review.

Zhou C, Jiao L, Qiao X, Zhang W, Chen S, Yang C Front Bioeng Biotechnol. 2024; 12:1424941.

PMID: 39045540 PMC: 11263083. DOI: 10.3389/fbioe.2024.1424941.


The Physiological Inorganic Polymers Biosilica and Polyphosphate as Key Drivers for Biomedical Materials in Regenerative Nanomedicine.

Muller W, Neufurth M, Wang S, Schroder H, Wang X Int J Nanomedicine. 2024; 19:1303-1337.

PMID: 38348175 PMC: 10860874. DOI: 10.2147/IJN.S446405.


Enhancing Stem Cell-Based Therapeutic Potential by Combining Various Bioengineering Technologies.

Hong I Front Cell Dev Biol. 2022; 10:901661.

PMID: 35865629 PMC: 9294278. DOI: 10.3389/fcell.2022.901661.


Stem Cell-Based Tissue Engineering for the Treatment of Burn Wounds: A Systematic Review of Preclinical Studies.

Lukomskyj A, Rao N, Yan L, Pye J, Li H, Wang B Stem Cell Rev Rep. 2022; 18(6):1926-1955.

PMID: 35150392 PMC: 9391245. DOI: 10.1007/s12015-022-10341-z.